Charles River Laboratories | Rövid Lejáratú Kötelezettségek



Current Liabilities változás Dátum
Agilent USD 1.87B 26M 2025-01
Align Technology USD 2.04B 25.59M 2024-12
Bio-Rad Laboratories USD 467.8M 30.14M 2024-12
Bruker USD 1.28B 37.5M 2024-12
Cardinal Health USD 35.22B 545M 2024-12
Charles River Laboratories USD 994.1M 18.12M 2024-12
Cigna USD 57.98B 919M 2024-12
CVS Health USD 84.61B 18M 2024-12
Danaher USD 6.8B 541M 2024-12
Dentsply International USD 1.59B 47M 2024-12
Elevance Health 40.36B 1.67B 2024-12
Galapagos EUR 335.08M 16.15M 2024-12
Hologic USD 1B 34.8M 2024-12
Humana 16.94B 1.79B 2024-12
Illumina USD 1.55B 572M 2024-12
Incyte USD 1.64B 140.2M 2024-12
IQVIA Holdings USD 6.96B 35M 2024-12
Laboratory Of America USD 3.33B 81.8M 2024-12
Lonza CHF 3.58B 970M 2024-12
McKesson USD 58.56B 209M 2024-12
Merck EUR 10.46B 532M 2024-09
Mettler Toledo International USD 1.17B 16.77M 2024-12
Novartis USD 28.69B 560M 2024-12
Pfizer USD 43B 216M 2024-12
Quest Diagnostics USD 2.17B 77M 2024-12
Revvity USD 653.1M 34.84M 2024-12
Thermo Fisher Scientific USD 13.33B 1.27B 2024-12
United Therapeutics USD 738.1M 135.3M 2024-12
UnitedHealth 103.77B 2.2B 2024-12
Walgreens Boots Alliance USD 27.45B 500M 2024-11
Waters USD 789.76M 26.28M 2024-12
West Pharmaceutical Services USD 550.4M 33.9M 2024-12



Charles River Laboratories Rövid Lejáratú Kötelezettségek - Az oldal aktuális és múlbeli adatokat, elorejelzéseket, statisztikákat, grafikonokat és a gazdasági naptár adatait tartalmazza - Mar 2025.